Mark Howard Snyder - 12 Jun 2024 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HALO	Restricted Stock Units	Award	$0	+20,137		$0.000000	20,137	12 Jun 2024	Common Stock	20,137	$0.000000	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The grant of restricted stock units reported on this Form 4 was awarded to Mr. Snyder in recognition of his contribution to the recent issuance of a European patent covering the Company's ENHANZE(R) rHuPH20 product that the Company provides to its licensees.
F2	This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.